Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.
about
Kidney disease: new technologies translate mechanisms to cureEmerging roles of extracellular vesicles in the nervous systemThe Treatment of Autosomal Dominant Polycystic Kidney DiseaseThe native TRPP2-dependent channel of murine renal primary ciliaVirtual-tissue computer simulations define the roles of cell adhesion and proliferation in the onset of kidney cystic diseaseKidney: polycystic kidney disease.Treatment of chronic kidney diseases with histone deacetylase inhibitors.Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA.New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol.Reciprocal regulation of cilia and autophagy via the MTOR and proteasome pathways.The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.Myristoylated CIL-7 regulates ciliary extracellular vesicle biogenesisHuman polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney diseaseHeterotrimeric G protein signaling in polycystic kidney diseaseSix2creFrs2α knockout mice are a novel model of renal cystogenesis.Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD.The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function.Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease.Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.Therapeutic Targets in Polycystic Liver Disease.Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency.Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.Advances in renal genetic diagnosis.Urinary proteomics for the study of genetic kidney diseases.AN INHIBITOR OF HISTONE DEACETYLASE 6 ACTIVITY, ACY-1215, REDUCES cAMP and CYST GROWTH IN POLYCYSTIC KIDNEY DISEASE.Sclt1 deficiency causes cystic kidney by activating ERK and STAT3 signaling.Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.ADPKD: clinical issues before and after renal transplantation.The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.Clinical Manifestation and Management of ADPKD in Western Countries.New Insights into the Molecular Mechanisms Targeting Tubular Channels/Transporters in PKD Development.Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease.The Sorting Nexin 3 Retromer Pathway Regulates the Cell Surface Localization and Activity of a Wnt-Activated Polycystin Channel Complex.Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage.
P2860
Q26825227-0259794C-F077-4A58-AC07-EBCED9B2FC78Q27025173-9FCD336F-6BDA-4971-9135-61585BE630BFQ28077060-3CE45F68-AAFF-4813-8358-44CCB91378C5Q28975616-EF64200E-4B64-46F1-AF4E-C011C3C73DADQ30834303-1DB4DBAC-1D07-483E-95FF-BA38FC597FC4Q34436755-2C9C5A6B-9AA2-44D0-B7C5-8832DEB8FC46Q35545347-9C89E0EC-365F-4DE9-BC2D-6CBBADB06461Q35718106-E2289C7C-9BC5-4192-8BD8-1D8F2BCA6A2CQ35834818-3FFE390D-4191-4EA3-A498-A9FB3AA62615Q35853049-B016D909-91DB-4DE3-B590-1FB15C40036DQ36003176-FC44A494-3475-4ABA-9402-83F400BD0DF6Q36063776-649A86D1-D435-4B48-9EF1-1265341108AEQ36167611-62225EB1-C424-4BC5-A8B6-69560B6E8823Q36624712-AF71C774-9131-4495-B3F7-A661540B0CADQ37017182-6DAB5905-4618-4C1C-9209-599802F6FDD0Q37139683-AFB42ADE-3C9C-4763-AEFA-B392D731FC8DQ37419990-3513081D-4B54-4F1C-B34F-83A251BC0293Q37426288-CB9A7810-6DC2-4ECC-8C54-BAC316653B7FQ37583250-4CFDDB4B-A039-4F05-8900-DFB5C8710373Q37630699-A8985F65-3D1E-4B4A-9220-11AD03B029F6Q38255110-18415B51-A8EA-4E28-8974-BF8ADBE59176Q38419495-CC191B1E-1DC5-4E46-ACE2-86177AAB259DQ38443908-04CCA1CD-3E28-4495-AE50-A724853F2ABEQ38645850-F0FCD7DA-0B37-4F13-A515-9D6638E3688BQ38668934-3AF86B98-D981-4B9E-88AF-C22D1F8B7025Q38673027-A7D420F1-EA31-4E03-915E-BCC2E89BDBE4Q38677349-331C1F3A-8676-4145-9313-0EAEF14E0BA1Q38696321-40452CD1-9A68-4CCC-86E7-689B1E263220Q38795694-64A068E3-E9D8-4513-8A28-A3DD214BD8BFQ38800191-0B3FB3D4-8F7B-4CD9-B0B7-5235504FAE56Q38868452-82A40F41-B711-4375-8C41-762AA8A28528Q38919283-3F017312-B07B-4862-AEFA-D7EBD912D025Q38987102-A532B74F-B08F-4DD0-92E8-468DC345F71CQ39030252-9D91588E-3B10-4533-9936-DC6276216EF5Q39030254-E888D61D-861B-4E22-A77C-3B118F1208A2Q39030255-BDD5F182-4FB6-47E6-BFA8-3F155E86921AQ39884248-976D3EDE-321B-4930-869A-2B5CF04729EBQ40170325-DF00721E-C160-4732-B11D-1DBF9B136FB5Q41247634-416305EF-B2CC-432D-AC08-06BAD8640849Q41815845-59CC51A4-A972-4CF2-B458-A42FB00CBC4B
P2860
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@ast
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@en
type
label
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@ast
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@en
prefLabel
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@ast
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@en
P2860
P356
P1476
Genetic mechanisms and signali ...... ant polycystic kidney disease.
@en
P2093
Peter C Harris
Vicente E Torres
P2860
P304
P356
10.1172/JCI72272
P407
P577
2014-06-02T00:00:00Z